Benoxinate Hydrochloride Production Cost Reports

The report provides a detailed analysis essential for establishing a Benoxinate hydrochloride production plant. It encompasses all critical aspects necessary for Benoxinate hydrochloride production, including the cost of Benoxinate hydrochloride production, Benoxinate hydrochloride plant cost, Benoxinate hydrochloride production costs, and the overall Benoxinate hydrochloride production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Benoxinate hydrochloride production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Benoxinate Hydrochloride is a local anaesthetic that finds applications in ophthalmology and otolaryngology. It serves as a local anaesthetic primarily in ophthalmology for corneal and conjunctival procedures. It is most commonly applied as an eye drop to numb the eye surface during diagnostic procedures such as tonometry, gonioscopy, and removal of foreign bodies or sutures. It helps reduce pain and discomfort by temporarily blocking nerve signals in the treated area. In addition to eye care, it may also be used on mucous membranes for short-term pain relief during certain medical procedures. Moreover, Benoxinate hydrochloride is also included in some formulations for contact lens fittings and certain minor eye surgeries. It is often used for procedures that require quick and temporary anaesthesia without long-lasting effects, due to its fast onset and short duration of action.

The demand for Benoxinate hydrochloride is primarily driven by its application as a local anaesthetic in ophthalmology before eye examinations and tonometry, which promotes its market expansion. Its usage to numb the surface of the eye during diagnostic and minor surgical procedures significantly promotes its demand in the medical and diagnostics sectors. Its demand as a preferred choice for temporary ocular anaesthesia in clinical practice due to its reliable anaesthetic effect and low systemic absorption also boosts its market growth. Its usage in eye examinations, such as tonometry and gonioscopy, and in minor surgical interventions further increases its demand in the medical and eye care centres.

Factors such as the availability and cost of active pharmaceutical ingredients, regulatory compliance related to drug safety and production standards, and environmental control measures greatly impact industrial Benoxinate hydrochloride procurement. Moreover, consistent supply chains, adherence to quality standards, and advancements in formulation technologies contribute to the sourcing and use of Benoxinate hydrochloride in pharmaceutical production worldwide.

Raw Material for Benoxinate Hydrochloride Production

According to the Benoxinate hydrochloride production plant project report, the major raw materials for Benoxinate hydrochloride production include 2,4-Difluoroaniline, Isoamyl Nitrite, Anisole, and Hydrogen Iodide.

Production Process of Benoxinate Hydrochloride

The extensive Benoxinate hydrochloride production cost report consists of the following industrial production process:

1. Production via Esterification: The production process of Benoxinate hydrochloride begins with the esterification of 3-oxy-4-nitrobenzoic acid to form its ethyl ester, which is then converted into a red potassium phenolate. Then, the obtained compound reacts with butyl bromide under heat to yield the butoxy-nitrobenzoic acid ethyl ester, which is further saponified to form 3-butoxy-4-nitrobenzoic acid. Then, this acid is reacted with thionyl chloride to produce the corresponding acid chloride, which is further condensed with diethylaminoethanol in benzene to give 3-butoxy-4-nitrobenzoic acid diethylaminoethyl ester. The final step involves catalytic hydrogenation of the nitro group using Raney nickel in alcohol to form the amine derivative. Finally, the product is converted to its hydrochloride salt by treatment with hydrogen chloride gas in ether, followed by recrystallisation, which results in the formation of Benoxinate hydrochloride as the final product.

Benoxinate hydrochloride is also known as Oxybuprocaine Hydrochloride. It is an ester-type local anaesthetic that is especially used in ophthalmology for topical anaesthesia of the eye. The free base appears as a colourless to light yellow viscous oil. Moreover, the molecular formula of the compound is C17H29ClN2O3, and its molecular weight is 344.88 g/mol. The compound has a melting point of 196 to 197 degree Celsius when recrystallised from alcohol and ether. It is freely soluble in water, alcohol, and chloroform but very slightly soluble in ether. It is marketed under various brand names, including Novesin, Dorsacaine, Conjucain, Lacrimin, and Benoxil. It is regarded as a toxicant, and nearly all patients experience a stinging or burning sensation upon application. It is recommended to use the medication with caution and avoid prolonged contact with the eye. Extended or repeated use may cause serious health problems, including corneal toxicity, severe corneal damage due to reduced corneal sensitivity, punctate keratitis, iritis, and moderate corneal swelling with accompanying visual impairment. The pharmaceutical preparations should be stored at controlled room temperature between 2 and 30 degree Celsius and protected from light.